Interesting Endo: T Trials & T1DM Self Care
Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.
Interesting T2DM: Diabetic Retinopathy & Drug News
Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.
Interesting T2DM: Peds Obesity & AHA Guides
Our February list includes updated guidelines for pediatric obesity, American Heart Assoc. statement on meal timing & frequency, and diabetes risks.
Endo News Roundup: CGM & Metformin Use
New studies review updated guidelines for metformin use, an examination of all-cause mortality in T2DM, and continuous glucose monitoring for T1DM.
Sexual Dysfunction in Diabetes
Asking about and treating sexual dysfunction may not only improve a patient’s quality of life, but also address serious health problems down the road.
Diabetic Dyslipidemia: Fenofibrate plus Statin
Further study is needed, but adding fenofibrate to statins may decrease cardiovascular disease events in certain patients with type 2 diabetes.
Diabetes & Ethnicity: Potential Life Years Lost
What role, if any, does ethnicity play in potential life years lost in patients with diabetes?
Statin Therapy with Type 2 Diabetes & Nephropathy
In patients with type 2 diabetes complicated by nephropathy, what is the real life effect of statin therapy on cardiovascular disease prevention?
CV Risks and Diabetes: Puerto Rican Population
Dr. Bobby Lazzara discusses a study looking at certain demographics and cardiovascular complications in a diabetic patient population in Puerto Rico.
Microvascular Disease Burden in Type 2 Diabetes
Does microvascular disease burden predict future cardiovascular events in type 2 diabetes? Dr. Bobby Lazzara discusses this question.
By clicking Accept, you agree to become a member of the UBM Medica Community.